The toxicity of the subsoil fumigant 1,3-dichloropropene (542756) (DCP) was reviewed, and the chemical properties and environmental fate of DCP were discussed. The commercially marketed formulation of DCP known as Telone-II consists of cis and trans DCP isomers. Both isomers are hydrolyzed to their corresponding 3-chloroallyl alcohols in wet soils. Halflives for hydrolytic degradation of the isomers have been estimated to be between 3 and 25 days at 20 degrees-C. Laboratory animal studies have indicated that the liver and kidney are target organs after acute and chronic oral exposure and the lung, liver, and kidney after inhalation exposure. DCP has shown eye and mucous membrane irritating properties. DCP appears to be metabolized primarily to mercapturic acid conjugates. DCP has demonstrated mutagenic activity in several tester strains of the Ames/Salmonella assay. DCP has demonstrated carcinogenic activity in rats and mice after oral or skin exposure. Preliminary results from an inhalation study have indicated that DCP is not carcinogenic. It was unclear whether DCP poses a cancer risk to humans. DCP has been shown to be a skin irritant. The liquid and vapor can be irritating to the eyes and mucous membranes. Evidence of hepatotoxicity (elevation of serum enzymes associated with liver function) has also been observed. The human health hazards posed by DCP were summarized. Due to its odor, exposure to high concentrations likely to cause injury are not considered likely under normal conditions. The author recommends that respiratory protection be used when DCP is handled. Contact with the eyes should be avoided.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.